Celyad Oncology SA (CYAD)
US1512052002 - ADR
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.88M | -26.51M | -17.20M | -28.63M | -37.43M | |||
| Depreciation Amortization | 1.44M | 1.52M | 1.83M | 1.79M | 1.11M | |||
| Change In Working Capital | -1.84M | 1.43M | -2.02M | -609.00K | 481.00K | |||
| Other non cash items | 13.27M | -3.08M | -10.28M | -749.00K | 8.58M | |||
| OPERATING CASH FLOW | -28.01M | -26.64M | -27.66M | -28.20M | -27.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -123.00K | -393.00K | -319.00K | -622.00K | -1.76M | |||
| Other Investing Activity | 7.33M | 267.00K | 476.00K | 9.61M | 2.37M | |||
| INVESTING CASH FLOW | 7.20M | -126.00K | 157.00K | 8.99M | 607.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.02M | -1.14M | -1.45M | -1.49M | 201.00K | |||
| Stock Issued/Repurchased | N/A | 36.57M | 0.00 | 16.45M | 43.01M | |||
| Other Financing Activity | 4.26M | 4.09M | 6.84M | 3.31M | 716.00K | |||
| FINANCING CASH FLOW | 3.24M | 39.52M | 5.40M | 18.28M | 43.93M | |||
| Exchange Rate Effect | -6.00K | 32.00K | 8.00K | -264.00K | 3.00K | |||
| CHANGE IN CASH | -17.57M | 12.78M | -22.10M | -1.20M | 17.29M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -28.01M | -26.64M | -27.66M | -28.20M | -27.25M | |||
| Capital Expenditure | -123.00K | -393.00K | -319.00K | -622.00K | -1.76M | |||
| FREE CASH FLOW | -28.13M | -27.04M | -27.98M | -28.82M | -29.01M | |||
All data in EUR